NASDAQ: VNDA Vanda Pharmaceuticals Inc. 10-Q

Vanda expands DC headquarters, extends lease through 2038 with partial space termination

Filed May 7, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 8, 2025 · ~1 min read

Key Changes

  • medium

    Company amended headquarters lease to expand premises while terminating certain space by November 2026, extending overall term through July 2038 with rent adjustments and tenant improvement allowances.

    Legal Proceedings verify on EDGAR →

See the full narrative summary and section-by-section diff — create a free account to read more. Takes 30 seconds.

Partner

Trade VNDA commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.